CymitQuimica logo

Atazanavir-d9

CAS:

Ref. TR-A790053

1mg
435.00€
10mg
2,940.00€
2500µg
1,001.00€
Atazanavir-d9
TRC

Product Information

Name:Atazanavir-d9
Controlled Product
Synonyms:
  • 3,12-Bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]-dimethyl Ester-d9
  • (3S,8S
  • 9S
  • 12S)-2,5,6,13-Pentaazatetradecanedioic Acid
  • BMS-232632-d9
  • CGP-73547-d9
Brand:TRC
Description:Applications Atazanavir-d9 is the deuterated analog of Atazanavir (A790051), a azapeptide HIV protease inhibitor derivative. Atazanavir have been investigated as potential treatment of human immunodeficiency virus (HIV) and for anticancer purposes.References Musial, B.L., et al.: Am. J. Health Syst. Pharm., 61, 1365 (2004), Wood, R., et al.: J. Acquir. Immune Defic. Syndr., 36, 684 (2004),
Notice:Our products are intended for lab use only. For any other use, please contact us.

Chemical properties

Molecular weight:719.95
Formula:C382H15H37N6O7
Color/Form:Neat
InChI:InChI=1S/C38H52N6O7/c1-37(2,3)31(41-35(48)50-7)33(46)40-29(21-25-13-10-9-11-14-25)30(45)24-44(43-34(47)32(38(4,5)6)42-36(49)51-8)23-26-16-18-27(19-17-26)28-15-12-20-39-22-28/h9-20,22,29-32,45H,21,23-24H2,1-8H3,(H,40,46)(H,41,48)(H,42,49)(H,43,47)/t29-,30-,31+,32+/m0/s1/i1D3,2D3,3D3,7D3,8D3
InChI key:InChIKey=AXRYRYVKAWYZBR-AJMYWNKJSA-N
SMILES:[2H]C([2H])([2H])C(C(NC(=O)OC)C(=O)N[C@@H](Cc1ccccc1)C(O)CN(Cc1ccc(-c2ccccn2)cc1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)(C([2H])([2H])[2H])C([2H])([2H])[2H]

Technical inquiry about: Atazanavir-d9

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
◻️
CYMIT QUÍMICA, S.L. as responsible for the treatment will treat your data in order to respond to your queries or requests. You can access, rectify and delete your data, as well as exercise other rights by consulting the additional and detailed information on data protection in our Web Privacy Policy.
* Mandatory fields.